| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $448.1M | -9.2% |
| R&D Expense | $135.1M | -29.4% |
| SG&A Expense | $181.9M | -16.6% |
| Operating Income | -$43.7M | +49.8% |
| Interest Expense | $3.0M | -1.0% |
| Pre-tax Income | -$40.6M | -450.8% |
| Income Tax | $15.7M | +26.3% |
| Net Income | -$56.3M | -302.2% |
| EPS (Basic) | -$1.23 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $96.8M | -25.8% |
| Accounts Receivable | $56.8M | -3.2% |
| Current Assets | $267.5M | -12.3% |
| Total Assets | $615.8M | -7.8% |
| Current Liabilities | $110.6M | -40.3% |
| Long-term Debt | $27.7M | +0.0% |
| Total Liabilities | $201.8M | -15.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$515K | +99.1% |
| Capital Expenditures | $5.4M | +6.8% |
| Investing Cash Flow | -$21.0M | -141.3% |
| Financing Cash Flow | -$12.2M | +36.7% |
| Free Cash Flow | -$5.9M | +90.2% |
| -296.8% |
| EPS (Diluted) | -$1.23 | -296.8% |
| Stockholders' Equity |
| $414.1M |
| -3.5% |